D Maraninchi

11.6k citations

259 papers · 8.5k · 2 hit papers · h-index 47

Impact in

Hematology top 0.1%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology

Papers in

Hematology 121
- Hematopoietic Stem Cell Transplantation 93
- Acute Myeloid Leukemia Research 46
Oncology 100
- Neutropenia and Cancer Infections 30
- Cancer Treatment and Pharmacology 29

Co-authors: Didier Blaise (95 shared papers)Patrice Viens (90 shared papers)Catherine Faucher (34 shared papers)Mauricette Michallet (13 shared papers)Michel Attal (15 shared papers)David Robert Grimes (4 shared papers)Aňa Lluch (3 shared papers)François Bertucci (27 shared papers)
Journals: Blood (17 papers)Bone Marrow Transplantation (17 papers)Journal of Clinical Oncology (11 papers)British Journal of Haematology (8 papers)Cancer (7 papers)
Partner nations: France United States Switzerland

In The Last Decade

D Maraninchi

255 papers receiving 8.2k citations

D Maraninchi's Hit Papers

align trajectories log scale

Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group. 2005 · 1.2k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2005 IRIS UNIMORE (University of Modena and Reggio Emilia)
1987 New England Journal of Medicine

Peers

Countries citing papers authored by D Maraninchi

Since Specialization

Citations

This map shows the geographic impact of D Maraninchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Maraninchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Maraninchi more than expected).

Fields of papers citing papers by D Maraninchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Maraninchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Maraninchi. The network helps show where D Maraninchi may publish in the future.

Co-authors

The 25 scholars most cited alongside D Maraninchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D Maraninchi Line = papers co-authored together D Maraninchi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 259 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group. IRIS UNIMORE (University of Modena and Reggio Emilia) ·Michel Marty, Francesco Cognetti, D Maraninchi, Ray Snyder, L. Mauriac, M. Tubiana-Hulin, Stephen Chan, David Robert Grimes, Antonio Antón, Aňa Lluch, John Kennedy, Kenneth J. O’Byrne, (unknown), (unknown), (unknown), (unknown), Pierfranco Conté Hit paper breakdown →	2005	1162
2	High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma New England Journal of Medicine ·Thierry Philip, Jamés O. Armitage, Gary Spitzer, Franck Chauvin, Sundar Jagannath, Jean‐Yves Cahn, Philippe Colombat, A H Goldstone, Norbert Claude Gorin, Michel Flesh, Jean-Philippe Laporte, D Maraninchi, J. L. Pico, André Bosly, Cathy M. Anderson, Rik Schots, Pierre Biron, Fernando Cabanillas, K. A. Dicke Hit paper breakdown →	1987	642
3	IMPACT OF T-CELL DEPLETION ON OUTCOME OF ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR STANDARD-RISK LEUKAEMIAS The Lancet ·D Maraninchi, Didier Blaise, Bernard Rio, V. Leblond, F. Dreyfus, Éliane Gluckman, Denis Guyotat, J L Pico, Mauricette Michallet, Norbert Ifrah, A. Bordigoni	1987	228
4	Gene Expression Profiling Shows Medullary Breast Cancer Is a Subgroup of Basal Breast Cancers Cancer Research ·François Bertucci, Pascal Finetti, Nathalie Cervera, Emmanuelle Charafe‐Jauffret, Émilie Mamessier, José Adélaı̈de, Stéphane Debono, Gilles Houvenaeghel, D Maraninchi, Patrice Viens, Colette Charpin, Jocelyne Jacquemier, Daniel Birnbaum	2006	218
5	Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging Blood ·NC Gorin, Philippe Aegerter, B Auvert, Giovanna Meloni, AH Goldstone, Alan K. Burnett, Angelo Michele Carella, M Körbling, P Hervé, D Maraninchi	1990	217
6	Protein Expression Profiling Identifies Subclasses of Breast Cancer and Predicts Prognosis Cancer Research ·Jocelyne Jacquemier, Christophe Ginestier, Jacques Rougemont, Valérie‐Jeanne Bardou, Emmanuelle Charafe‐Jauffret, Jeannine Geneix, José Adélaı̈de, Alane Koki, Gilles Houvenaeghel, J Hassoun, D Maraninchi, Patrice Viens, Daniel Birnbaum, François Bertucci	2005	174
7	Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse [see comments] Blood ·Didier Blaise, D Maraninchi, E Archimbaud, J Reiffers, A Devergié, J.P. Jouet, Nöel Milpied, Michel Attal, Mauricette Michallet, Norbert Ifrah	1992	174
8	Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin–based reduced-intensity preparative regimen Blood ·Mohamad Mohty, Jacques‐Olivier Bay, Catherine Faucher, Bachra Choufi, Karin Bilger, Olivier Tournilhac, Norbert Vey, Anne‐Marie Stoppa, Diane Coso, Christian Chabannon, Patrice Viens, D Maraninchi, Didier Blaise	2003	152
9	Gene Expression Profiling for Molecular Characterization of Inflammatory Breast Cancer and Prediction of Response to Chemotherapy Cancer Research ·François Bertucci, Pascal Finetti, Jacques Rougemont, Emmanuelle Charafe‐Jauffret, Valéry Nasser, Béatrice Loriod, Jacques Camerlo, Rebecca Tagett, Carole Tarpin, Gilles Houvenaeghel, Catherine Nguyen, D Maraninchi, Jocelyne Jacquemier, Rémi Houlgatte, Daniel Birnbaum, Patrice Viens	2004	144
10	Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse [see comments] Blood ·Didier Blaise, D Maraninchi, E Archimbaud, J Reiffers, A Devergié, J P Jouet, Nöel Milpied, Michel Attal, Mauricette Michallet, Norbert Ifrah	1992	140
11	Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia Cancer ·Anne Etienne, Benjamin Esterni, Aude Charbonnier, Julien Mozziconacci, Christine Arnoulet, Diane Coso, Brigitte Puig, Jean‐Albert Gastaut, D Maraninchi, Norbert Vey	2007	130
12	Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia. Journal of Clinical Oncology ·Catherine Sebban, Éric Lepage, J P Vernant, Éliane Gluckman, Michel Attal, J Reiffers, Laurent Sutton, E Racadot, M Michallet, D Maraninchi	1994	130
13	Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy Oncogene ·Anthony Gonçalvès, B. Esterni, François Bertucci, R Sauvan, C Chabannon, Myriam Cubizolles, V J Bardou, G Houvenaegel, Jocelyne Jacquemier, Samuel Granjeaud, Meng Xy, Eileen Fung, Daniel Birnbaum, D Maraninchi, Patrice Viens, Jean‐Paul Borg	2005	102
14	Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation Leukemia ·Mohamad Mohty, Karin Bilger, Éric Jourdan, Mathieu Kuentz, Mauricette Michallet, Jean Henri Bourhis, Nöel Milpied, Laurent Sutton, J. P. Jouet, Michel Attal, Pierre Bordigoni, J Cahn, Alain Sadoun, Norbert Ifrah, Denis Guyotat, Catherine Faucher, Nathalie Fegueux, Josy Reiffers, D Maraninchi, Didier Blaise	2003	101
15	High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation Bone Marrow Transplantation ·Mohamad Mohty, Catherine Faucher, Norbert Vey, A. M. Stoppa, F. Viret, Ingrid Chabbert, Christian Chabannon, Réda Bouabdallah, Patrick Ladaique, L. Collet, Christine Zandotti, D Maraninchi, Didier Blaise	2000	100
16	Phase III Double-Blind, Placebo-Controlled Study of Thalidomide in Extensive-Disease Small-Cell Lung Cancer After Response to Chemotherapy: An Intergroup Study FNCLCC cleo04–IFCT 00-01 Journal of Clinical Oncology ·Jean Louis Pujol, Jean Luc Breton, Radj Gervais, Marie‐Laure Tanguy, Élisabeth Quoix, Philippe David, Henri Janicot, Virginie Westeel, Sabine Gameroff, Jean Genève, D Maraninchi	2007	97
17	Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission: a prospective controlled trial British Journal of Haematology ·Josy Reiffers, M Gaspard, D Maraninchi, Mauricette Michallet, Gérald Marit, A.-M. Stoppa, Bernadette Corront, B. David, J.A. Gastaut, J J Sotto, A Broustet, Y Carcassonne, D Hollard	1989	93
18	Allogeneic vs autologous stem cell transplantation vs chemotherapy in patients with acute myeloid leukemia in first remission: the BGMT 87 study. PubMed ·Josy Reiffers, Anne Marie Stoppa, Michel Attal, Marie‐Cécile Michallet, Gérald Marit, Didier Blaise, F. Huguet, Bernadette Corront, P Cony-Makhoul, J A Gastaut, G. Laurent, Lysiane Molina, A Broustet, D Maraninchi, J Pris, D Hollard, C. Fabères	1996	86
19	DETECTION OF RESIDUAL bcr/abl TRANSLOCATION BY POLYMERASE CHAIN REACTION IN CHRONIC MYELOID LEUKAEMIA PATIENTS AFTER BONE-MARROW TRANSPLANTATION The Lancet ·J Gäbert, M. Lafage, D Maraninchi, Isabelle Thuret, Y Carcassonne, P Mannoni	1989	82
20	Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen Leukemia ·Mohamad Mohty, William Jacot, Catherine Faucher, Jacques‐Olivier Bay, Christine Zandotti, L. Collet, B Choufi, Karin Bilger, Olivier Tournilhac, Norbert Vey, A. M. Stoppa, Diane Coso, J.A. Gastaut, Patrice Viens, D Maraninchi, Daniel Olive, Didier Blaise	2003	80

About D Maraninchi

D Maraninchi is a scholar working on Hematology, Oncology, Immunology, Public Health, Environmental and Occupational Health and Pathology and Forensic Medicine, having authored 259 papers that have together received 8.5k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (93 papers), Acute Myeloid Leukemia Research (46 papers), Neutropenia and Cancer Infections (30 papers), Cancer Treatment and Pharmacology (29 papers), Lymphoma Diagnosis and Treatment (27 papers), Acute Lymphoblastic Leukemia research (24 papers), T-cell and B-cell Immunology (22 papers) and Chronic Lymphocytic Leukemia Research (21 papers). The work is most often cited by research in Hematology (3.7k citations), Oncology (3.8k citations), Genetics (1.0k citations), Pathology and Forensic Medicine (1.4k citations) and Cancer Research (1.1k citations). D Maraninchi has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Didier Blaise, Patrice Viens, Catherine Faucher, Mauricette Michallet, Michel Attal, David Robert Grimes, Aňa Lluch, François Bertucci, L. Mauriac and John Kennedy. Their work appears in journals such as Blood, Bone Marrow Transplantation, Journal of Clinical Oncology, British Journal of Haematology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

D Maraninchi

Impact in

Papers in i

In The Last Decade

D Maraninchi

D Maraninchi's Hit Papers

Peers

Countries citing papers authored by D Maraninchi

Fields of papers citing papers by D Maraninchi

All Works

About D Maraninchi

Explore authors with similar magnitude of impact

Papers in